Mahmud Ibrahim, MD
Sports Medicine · East Brunswick, NJNPI 1669633558
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $3,156 of the $4,943 with a category attached, or 63.8%. 20 manufacturers reported payments, led by Si-bone, Inc. at 29.1% of the total. Reporting peaked in 2024 at $2,567 and has fallen 88.3% since, to $299 in 2025.
Across 166 payments — averaging $29.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Si-bone, Inc.$1K
- Collegium Pharmaceutical, Inc.$1K
- Boston Scientific$846
- Protega Pharmaceutials Inc$779
- Medtronic$249
- Arbor Pharmaceuticals, Inc.$136
- plus $479 from 14 others
What the payments were for
- Speaking & faculty fees$60012%
- Travel & lodging$1,18524%
- Food & beverage$3,15664%
- Education$30%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Si-bone, Inc. | 10 | $1,439 |
| Collegium Pharmaceutical, Inc. | 73 | $1,014 |
| Boston Scientific | 28 | $846 |
| Protega Pharmaceutials Inc | 12 | $779 |
| Medtronic(2 entities) | 5 | $249 |
| Arbor Pharmaceuticals, Inc. | 8 | $136 |
| Forte Bio-pharma LLC | 7 | $115 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 4 | $56 |
| Nevro Corp. | 3 | $55 |
| Johnson & Johnson | 3 | $52 |
| Bioventus LLC | 2 | $42 |
| Avanos Medical | 2 | $40 |
| Pfizer | 2 | $29 |
| Virtus Pharmaceuticals LLC | 1 | $16 |
| Sanofi-aventis U.S. LLC | 1 | $15 |
| Kaleo, Inc. | 1 | $14 |
| Ferring Pharmaceuticals Inc. | 1 | $14 |
| Abbott | 1 | $13 |
| AstraZeneca | 1 | $11 |
| Electronic Waveform Lab, Inc. | 1 | $7 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,943 in reported general payments places this provider in the 75th percentile of 221 sports medicine providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OxycontinOxycodone Hcl | 47 | $94,145 |
| Xtampza ErOxycodone Myristate | 24 | $33,858 |
| Buprenorphine | 11 | $4,530 |
| Oxycodone Hcl | 156 | $3,798 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 47 | $1,381 |
| Morphine Sulfate ErMorphine Sulfate | 30 | $622 |
| Pregabalin | 45 | $587 |
| Cyclobenzaprine Hcl | 29 | $354 |
| Tramadol Hcl | 70 | $286 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 12 | $243 |
| Ibuprofen | 24 | $168 |
| Naproxen | 18 | $137 |
| Meloxicam | 35 | $74 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 11 | $52 |
| Methylprednisolone | 11 | $21 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Xtampza Er | $1,014 | $33,85824 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 221 sports medicine providers in New Jersey.
Other sports medicine in East Brunswick
- Sean McMillanBurlington$1.8M
- Nicholas JarmonFreehold$277K
- Thomas YoumEnglewood$221K
- Stephen HuntCedar Knolls$76K
- David PorterHackensack$63K
- Francis AlbertaHackensack$61K
- Nathan HolmesSewell$56K
- Steven FreyWoodbury$55K
- Lon CastleFranklin Lakes$54K
- Dante MarconiSomers Point$49K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.